Coya

is a Texas-based clinical-stage biotechnology firm that researches and develops T-cell-modulating therapies for neurodegenerative, autoimmune, and metabolic diseases...
Read more
Coya CEO: Arun Swaminathan

CEO

Arun Swaminathan

CEO Approval Rating

- -/100

Annual Revenue
$4M
Employees
6
Funding
$87.5M

Coya Competitors

1Xencor
2Mozart
3Evox
4Acurx Pharmaceuticals
5Abeona Therapeutics
6Sensei Bio
7Avalo
8MEI Pharma
9ASLAN Pharmaceuticals
10Gain

Trending Companies